NCT02094131

Brief Summary

Experimental Procedure: The subjects underwent an initial interview in which was filled in a form of anamnesis, in addition to being assessed and reassessed by spirometry, dynamic circumference and manometer. Moreover, responded international physical activity questionnaire (IPAQ - short version) in order to characterize the physical activity level of each participant being classified as inactive, irregularly active, active, and very active. The same examiner performed the assessments and reassessments of individuals after a training program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Oct 2010

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

March 13, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 21, 2014

Completed
Last Updated

March 21, 2014

Status Verified

March 1, 2014

Enrollment Period

5 months

First QC Date

March 13, 2014

Last Update Submit

March 20, 2014

Conditions

Keywords

incentive spirometryflow-oriented spirometervolume-oriented spirometerphysical therapyrespiratory muscle training

Outcome Measures

Primary Outcomes (1)

  • Pulmonary Function Testing (Spirometry)

    vital capacity (VC) (%predicted) peak expiratory flow (PEF) (%predicted) forced vital capacity (FVC) (%predicted) forced expiratory volume in one second (FEV1) (%predicted) forced expiratory volume in one second/forced vital capacity ratio (FEV1/FVC) maximum voluntary ventilation (MVV) (%predicted)

    up to 5 weeks

Secondary Outcomes (1)

  • Respiratory muscle strength (Maximal inspiratory and expiratory pressures-manometer)

    Baseline and 5 weeks

Other Outcomes (1)

  • Thoracoabdominal Mobility (Cirtometry Dynamics)

    Baseline and 5 weeks

Study Arms (3)

Cliniflo group (CG)

EXPERIMENTAL

Training using flow-oriented incentive spirometry Cliniflo

Other: Cliniflo group (CG)

Voldyne group (VG)

EXPERIMENTAL

Training using volume-oriented incentive spirometry Voldyne

Other: Voldyne group (VG)

Control group (CONG)

NO INTERVENTION

No intervention. Assessment and reassessment after 5 weeks.

Interventions

VG: slow deep breaths through the mouthpiece of the incentive Voldyne5000® were conducted from the tidal volume (TV) until the total lung capacity (TLC), holding the maximum inspiration. All individuals should maintain "yellow cup" ("yellow flow cup") at a range of flow "Best" in as long as possible. The training lasted approximately 50 minutes, were held twice a week on alternate days, for five consecutive weeks, totaling 10 sessions. Performed three sets of 15 repetitions.

Voldyne group (VG)

CG: slow deep breaths through the mouthpiece of the incentive Cliniflo® from tidal volume (TV) were performed until the total lung capacity (TLC), holding the maximum inspiration. The volume flow of 100 ml / s for Cliniflo® was standardized, being envisaged to keep the yellow indicator behind the "happy face" for all individuals.The training lasted approximately 50 minutes, were held twice a week on alternate days, for five consecutive weeks, totaling 10 sessions. Performed three sets of 15 repetitions.

Cliniflo group (CG)

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18 and 30 years
  • Spirometric values within normal limits
  • Body mass index (BMI) between 18 and 29.9 (kg/m2)
  • Without previous or current history of smoking
  • Did not report the presence of neuromuscular, respiratory or cardiac disease

You may not qualify if:

  • Inability to understand and / or perform procedures
  • Physically active and very active individuals

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ivanize Mariana Masselli dos Reis

São Carlos, São Paulo, 13565-905, Brazil

Location

Related Publications (5)

  • Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983 Jun;127(6):725-34. doi: 10.1164/arrd.1983.127.6.725.

  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten C, Gustafsson P, Jensen R, Macintyre N, McKay RT, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of lung function testing: the authors' replies to readers' comments. Eur Respir J. 2010 Dec;36(6):1496-8. doi: 10.1183/09031936.00130010. No abstract available.

  • Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis. 1969 May;99(5):696-702. doi: 10.1164/arrd.1969.99.5.696. No abstract available.

  • Neder JA, Andreoni S, Lerario MC, Nery LE. Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res. 1999 Jun;32(6):719-27. doi: 10.1590/s0100-879x1999000600007.

  • Restrepo RD, Wettstein R, Wittnebel L, Tracy M. Incentive spirometry: 2011. Respir Care. 2011 Oct;56(10):1600-4. doi: 10.4187/respcare.01471.

Study Officials

  • Ivanize Mariana M dos Reis, Specialist

    Universidade Federal de Sao Carlos

    PRINCIPAL INVESTIGATOR
  • Mauricio Jamami, PhD

    Universidade Federal de Sao Carlos

    STUDY DIRECTOR
  • Bruna V Pessoa, PhD

    Universidade Federal de Sao Carlos

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist

Study Record Dates

First Submitted

March 13, 2014

First Posted

March 21, 2014

Study Start

October 1, 2010

Primary Completion

March 1, 2011

Study Completion

December 1, 2011

Last Updated

March 21, 2014

Record last verified: 2014-03

Locations